🇺🇸 FDA
Patent

US 9302013

Active principle for mitigating undesired medical conditions

granted A61KA61K31/765A61K31/785

Quick answer

US patent 9302013 (Active principle for mitigating undesired medical conditions) held by TERMIRA AB expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TERMIRA AB
Grant date
Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/765, A61K31/785, A61K31/787, A61K47/32